Terrestrial support of pelagic consumers: patterns and variability revealed by a multilake study

相似文献   

Capercaillie Tetrao urogallus abundance and habitat use in Scotland,in winter 1998–99

CapsuleA second full survey in which we estimate the population at 1073 birds (95% CL 549–2041).

Aims To provide an up-to-date estimate of the population size of Capercaillie in Britain and to identify habitat use by Capercaillie in winter.

Methods Using the census technique of distance sampling, flushed birds were counted along line transects walked in stratified random blocks of forest within the species' range. The same transects were surveyed as used in the 1992–94 survey, enabling direct comparison of the results. Densities were estimated using the DISTANCE program, combining these data with those from a similar survey of Capercaillie in 1992–94 to allow a more robust estimate of the detection function.

Results The Capercaillie population was estimated to be 1073 birds (95% CL 549–2041). This represents a decline of 51% between the two surveys, at a rate of 13% per annum. Females declined at a faster rate than males resulting in a marked change in the sex-ratio, which was close to 1:1 for the entire population. Bird densities declined by a similar magnitude in both native pinewoods and other woodlands in comparison to 1992–94. Even so, densities were significantly higher in native pinewoods (1.63 km^-2) than in other woodlands (0.43 km^-2), which comprised largely planted Scots Pine Pinus sylvestris, larch Larix spp., Lodgepole Pine Pinus contorta and Sitka Spruce Picea sitchensis. Overall, Capercaillie tended to use forest stands with a high proportion of Scots Pine and Blaeberry Vaccinium myrtilus; features that are typical of native pinewoods and old pine plantations.

Conclusions The Capercaillie population has undergone a dramatic decline during the last five years. The decline has been greater for females and has occurred across habitats. This information is helping to focus efforts in securing the future for Capercaillie in Scotland, which has now become a major conservation challenge.     

The marine algae of Orkney

Six species are described and compared with related algae. All were isolated in culture from terrestrial habitats on Signy Island, South Orkney Islands, Antarctica. They are: Botrydiopsis constricta sp. nov. (Mischococcales, Xanthophyceae), Heterothrix antarctica sp. nov. (Tribonematales, Xanthophyceae), Sphaerocystis oleifera sp. nov. (Chlorococcales, Chlorophyceae), Sphaerocystis signiensis sp. nov., Sphaerocystis bilobata sp. nov. and Fottea pyrenoidosa sp. nov. (Ulothricales, Chlorophyceae).     

Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis

Background

HIV-associated tuberculosis is a common coinfection in Sub-Saharan Africa, which causes high morbidity and mortality. A sub-set of HIV-associated tuberculosis patients require prolonged hospital admission, during which antiretroviral therapy initiation may be required. The aim of this study was to document the causes of clinical deterioration of hospitalised patients with HIV-associated tuberculosis starting antiretroviral therapy in order to inform healthcare practice in low- to middle-income countries.

Methods

Prospective, observational cohort study of adult inpatients with HIV-associated tuberculosis starting antiretroviral therapy in a dedicated tuberculosis hospital in Cape Town, South Africa. Causes of clinical deterioration and outcome were recorded in the first 12 weeks of antiretroviral therapy. Patients with rifampicin-resistant tuberculosis were excluded.

Results

Between May 2009 and November 2010, 112 patients (60% female), with a median age of 32 years were enrolled. At baseline the median CD4 count was 55 cells/mm³ (IQR 31–106) and HIV viral load 5.6 log copies/mL. All patients had significant comorbidity: 82% were bed-bound, 65% had disseminated tuberculosis and 27% had central nervous system tuberculosis. Seventy six patients (68%) developed 144 clinical events after starting antiretroviral therapy. TB-IRIS, hospital-acquired infections and significant drug toxicities occurred in 42%, 20.5% and 15% of patients respectively. A new opportunistic disease occurred in 15% of patients and a thromboembolic event in 8%. Mortality during the 12 week period was 10.6%.

Conclusions

High rates of TB-IRIS, hospital-acquired infections and drug toxicities complicate the course of patients with HIV-associated tuberculosis starting antiretroviral therapy in hospital. Despite the high morbidity, mortality was relatively low. Careful clinical management and adequate resources are needed in hospitalised HIV-TB patients in the 1^st three months following ART initiation.     

Why is the world green? The interactions of top–down and bottom–up processes in terrestrial vegetation ecology

A classic question in plant ecology is “why is the world green?” That is, if plants are food for animals why do not animals eat all the available food – changing a ‘green world’ into a ‘brown world’. We first reviewed this question in 2009 and now revisit our arguments in the light of new data and new thinking. Here we argue that (1) the top–down bottom–up dichotomy is probably too simple for understanding a complex system – such as vegetation – rich in feedback processes. (2) Nevertheless it appears that bottom–up processes are generally more important for maintaining the presence of some sort of vegetation while top–down control process are generally more important in determining the type of vegetation at a site. (3) Although this review mainly takes a qualitative and experimental approach to the question, we also argue that simple well-known mathematical models from population ecology can be very informative in thinking about the types of explanations for the green world phenomenon, and demonstrating that it is rarely a simple choice between one form of control or another.     

Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences

Simian-human immunodeficiency virus (SHIV) challenge stocks are critical for preclinical testing of vaccines, antibodies, and other interventions aimed to prevent HIV-1. A major unmet need for the field has been the lack of a SHIV challenge stock expressing circulating recombinant form 01_AE (CRF01_AE) env sequences. We therefore sought to develop mucosally transmissible SHIV challenge stocks containing HIV-1 CRF01_AE env derived from acutely HIV-1 infected individuals from Thailand. SHIV-AE6, SHIV-AE6RM, and SHIV-AE16 contained env sequences that were >99% identical to the original HIV-1 isolate and did not require in vivo passaging. These viruses exhibited CCR5 tropism and displayed a tier 2 neutralization phenotype. These challenge stocks efficiently infected rhesus monkeys by the intrarectal route, replicated to high levels during acute infection, and established chronic viremia in a subset of animals. SHIV-AE16 was titrated for use in single, high dose as well as repetitive, low dose intrarectal challenge studies. These SHIV challenge stocks should facilitate the preclinical evaluation of vaccines, monoclonal antibodies, and other interventions targeted at preventing HIV-1 CRF01_AE infection.